Cowen Has Just Reaffirmed $250 Target Price Per Share on Lam Research (NASDAQ:LRCX) stock, While They’ve Also Reiterated Their “Outperform” Rating

July 27, 2018 - By Pearl Odom

Lam Research Corporation (NASDAQ:LRCX) Logo

Investors sentiment increased to 1.1 in 2018 Q1. Its up 0.02, from 1.08 in 2017Q4. It increased, as 62 investors sold Lam Research Corporation shares while 259 reduced holdings. 131 funds opened positions while 223 raised stakes. 138.23 million shares or 1.88% less from 140.89 million shares in 2017Q4 were reported.

Liberty Mutual Group Asset Mngmt invested 0.04% of its portfolio in Lam Research Corporation (NASDAQ:LRCX). Macquarie Group Inc holds 0.01% or 36,346 shares. Vermont-based Manchester Cap Llc has invested 0.05% in Lam Research Corporation (NASDAQ:LRCX). Moreover, Eagle Asset Management has 0.02% invested in Lam Research Corporation (NASDAQ:LRCX). Northwestern Mutual Wealth Mngmt stated it has 0% in Lam Research Corporation (NASDAQ:LRCX). Citadel Advsrs Ltd Co reported 0.19% stake. Moreover, Twin Tree Mgmt Lp has 0.07% invested in Lam Research Corporation (NASDAQ:LRCX). Pathstone Family Office Ltd Co holds 0.02% of its portfolio in Lam Research Corporation (NASDAQ:LRCX) for 200 shares. Moreover, M&T Retail Bank has 0.03% invested in Lam Research Corporation (NASDAQ:LRCX). 4,664 are held by Winslow Evans Crocker. Aqr Capital Management Lc has invested 0.24% of its portfolio in Lam Research Corporation (NASDAQ:LRCX). Quantitative Invest Mngmt Ltd Liability Com holds 0.45% or 126,500 shares. Virtu Financial Limited Liability Corp holds 0.35% or 32,289 shares. Burney stated it has 92,033 shares. Tnb owns 1,039 shares.

Since March 7, 2018, it had 0 insider buys, and 11 insider sales for $23.06 million activity. $390,194 worth of Lam Research Corporation (NASDAQ:LRCX) was sold by O’Dowd Sarah A. 6,465 shares were sold by ARCHER TIMOTHY, worth $1.39M. 11,200 shares were sold by Anstice Martin B, worth $2.52M. Shares for $987,770 were sold by LORD PATRICK J.

Lam Research (NASDAQ:LRCX) Rating Reaffirmed

In a research report sent to investors and clients on Friday, 27 July, The “Outperform” rating of Lam Research (NASDAQ:LRCX) shares was maintained by Cowen, who now has a $250 PT on the stock. Cowen’s PT gives a possible upside of 41.04 % from the current price of the company.

Lam Research Corporation (NASDAQ:LRCX) Ratings Coverage

Among 14 analysts covering Lam Research (NASDAQ:LRCX), 13 have Buy rating, 0 Sell and 1 Hold. Therefore 93% are positive. Lam Research has $305.0 highest and $210 lowest target. $268.36’s average target is 51.39% above currents $177.26 stock price. Lam Research had 20 analyst reports since March 7, 2018 according to SRatingsIntel. The rating was maintained by FBR Capital with “Buy” on Wednesday, April 18. The rating was maintained by Citigroup on Friday, July 13 with “Buy”. The stock of Lam Research Corporation (NASDAQ:LRCX) has “Buy” rating given on Tuesday, March 6 by Susquehanna. The firm earned “Buy” rating on Thursday, April 12 by KeyBanc Capital Markets. B. Riley & Co maintained the shares of LRCX in report on Wednesday, April 18 with “Buy” rating. The firm has “Buy” rating given on Tuesday, June 26 by UBS. The rating was maintained by KeyBanc Capital Markets with “Overweight” on Wednesday, March 7. As per Friday, May 18, the company rating was maintained by Mizuho. On Wednesday, April 18 the stock rating was maintained by KeyBanc Capital Markets with “Overweight”. The rating was maintained by Stifel Nicolaus with “Buy” on Wednesday, April 18.

The stock increased 2.58% or $4.46 during the last trading session, reaching $177.26. About 2.93 million shares traded. Lam Research Corporation (NASDAQ:LRCX) has risen 31.27% since July 27, 2017 and is uptrending. It has outperformed by 18.70% the S&P500.

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits worldwide. The company has market cap of $29.08 billion. The firm offers thin film deposition products, including SABRE electrochemical deposition products for copper damascene manufacturing; ALTUS systems to deposit conformal atomic layer films for tungsten metallization applications; VECTOR plasma-enhanced chemical vapor deposition and atomic layer deposition systems to deposit oxides, nitrides, and carbides for hardmasks, multiple patterning films, anti-reflective layers, multi-layer stack films, and diffusion barriers; and Striker atomic layer deposition systems that deliver conformal dielectric films for spacer patterning and liner applications in various advanced memory and logic structures. It has a 17.23 P/E ratio. The Company’s thin film deposition products also comprise SPEED high-density plasma CVD products for applications in shallow trench isolation, pre-metal dielectrics, inter-layer dielectrics, inter-metal dielectrics, and passivation layers; and SOLA ultraviolet thermal processing products for treatment of back-end-of-line (BEOL) low-k dielectric films and front-end-of-line silicon nitride strained films.

More notable recent Lam Research Corporation (NASDAQ:LRCX) news were published by: Nasdaq.com which released: “Lam Research Corporation Reports Financial Results for the Quarter Ended June 24, 2018” on July 26, 2018, also Seekingalpha.com with their article: “Evercore, Cowen name semi picks ahead of earnings” published on July 17, 2018, Fool.com published: “Better Buy: Lam Research vs. Applied Materials” on July 17, 2018. More interesting news about Lam Research Corporation (NASDAQ:LRCX) were released by: Seekingalpha.com and their article: “Lam Research (LRCX) Q4 2018 Results – Earnings Call Transcript” published on July 27, 2018 as well as Seekingalpha.com‘s news article titled: “Big Week Of Earnings For Chip Sector: Which Companies Are Set Up For The Biggest Moves” with publication date: July 23, 2018.

Lam Research Corporation (NASDAQ:LRCX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.